Kabra Drugs Ltd

Kabra Drugs Ltd. Shares Compliance Update for Q4 2025 📄

- Kabra Drugs Ltd. submitted a compliance certificate for the quarter ended December 31, 2025.

- Skyline Financial Services Pvt Ltd, the Registrar and Share Transfer Agent, issued the certificate.

- Physical share certificates were processed in line with SEBI regulations.

- Certificates were verified, mutilated, and cancelled within 15 days.

- The company’s securities remain listed on the same stock exchange as before.

- BSE Scrip Code: 524322.